|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kew MC: Hepatocellular carcinoma:
Epidemiology and risk factors. J Hepatocell Carcinoma. 1:115–125.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Buonaguro L, Petrizzo A, Tagliamonte M,
Tornesello ML and Buonaguro FM: Challenges in cancer vaccine
development for hepatocellular carcinoma. J Hepatol. 59:897–903.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kondo R, Nakashima O, Tanikawa K, Nomura Y
and Kage M: Accumulation of platelets in the liver may be an
important contributory factor to thrombocytopenia and liver
fibrosis in chronic hepatitis C. J Gastroenterol. 48:526–534. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li N: Platelets in cancer metastasis: To
help the ‘villain’ to do evil. Int J Cancer. 138:2078–2087. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang LQ, Xu XS, Wan Y, Song SD, Wang RT,
Chen W, Wang ZX, Chang HL, Wei JC, Dong YF and Liu C: Prognostic
implications of estrogen receptor 1 and vascular endothelial growth
factor A expression in primary gallbladder carcinoma. World J
Gastroenterol. 21:1243–1250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sullivan BH Jr and Tumen HJ: The effect of
portacaval shunt on thrombocytopenia associated with portal
hypertension. Ann Intern Med. 55:598–603. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Felix WR Jr, Myerson RM, Sigel B, Perrin
EB and Jackson FC: The effect of portacaval shunt on hypersplenism.
Surg Gynecol Obstet. 139:899–904. 1974.PubMed/NCBI
|
|
9
|
Hoffman R, Haim N and Brenner B: Cancer
and thrombosis revisited. Blood Rev. 15:61–67. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Donati MB and Falanga A: Pathogenetic
mechanisms of thrombosis in malignancy. Acta Haematol. 106:18–24.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo F, Zhu X and Qin X: Platelet
distribution width in hepatocellular carcinoma. Med Sci Monit.
24:2518–2523. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Labelle M, Begum S and Hynes RO: Direct
signaling between platelets and cancer cells induces an
epithelial-mesenchymal-like transition and promotes metastasis.
Cancer Cell. 20:576–590. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bambace NM and Holmes CE: The platelet
contribution to cancer progression. J Thromb Haemost. 9:237–249.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oft M, Peli J, Rudaz C, Schwarz H, Beug H
and Reichmann E: TGF-beta1 and Ha-Ras collaborate in modulating the
phenotypic plasticity and invasiveness of epithelial tumor cells.
Genes Dev. 10:2462–77. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pang Q, Qu K, Bi JB, Liu SS, Zhang JY,
Song SD, Lin T, Xu XS, Wan Y, Tai MH, et al: Thrombocytopenia for
prediction of hepatocellularcarcinoma recurrence: Systematic review
and meta-analysis. World J Gastroenterol. 21:7895–7906. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wai CT, Greenson JK, Fontana RJ,
Kalbfleisch JD, Marrero JA, Conjeevaram HS and Lok SF: A simple
noninvasive index can predict both significant fibrosis and
cirrhosis in patients with chronic hepatitis C. Hepatology.
38:518–526. 2010. View Article : Google Scholar
|
|
17
|
Sterling RK, Lissen E, Clumeck N, Sola R,
Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT,
Thomas DL, et al: Development of a simple noninvasive index to
predict significant fibrosis in patients with HIV/HCV coinfection.
Hepatology. 43:1317–1325. 2010. View Article : Google Scholar
|
|
18
|
Pohl A, Behling C, Oliver D, Kilani M,
Monson P and Hassanein T: Serum aminotransferase levels and
platelet counts as predictors of degree of fibrosis in chronic
hepatitis C virus infection. Am J Gastroenterol. 96:3142–3146.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hsieh YY, Tung SY, Lee IL, Lee K, Shen CH,
Wei KL, Chang TS, Chuang CS, Wu CS and Lin YH: FibroQ: An easy and
useful noninvasive test for predicting liver fibrosis in patients
with chronic viral hepatitis. Chang Gung Med J. 32:614–622.
2009.PubMed/NCBI
|
|
20
|
Lok AS, Ghany MG, Goodman ZD, Wright EC,
Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di
Bisceglie AM, et al: Predicting cirrhosis in patients with
hepatitis C based on standard laboratoiy tests: Results of the
HALT-C cohort. Hepatology. 42:282–292. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang HW, Peng CY, Lai HC, Su WP, Lin CH,
Chuang PH, Chen SH, Chen CH, Hsu WF and Huang GT: New noninvasive
index for predicting liver fibrosis in Asian patients with chronic
viral hepatitis. Sci Rep. 7:32592017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bonacini M, Hadi G, Govindarajan S and
Lindsay KL: Utility of a discriminant score for diagnosing advanced
fibrosis or cirrhosis in patients with chronic hepatitis C virus
infection. Am J Gastroenterol. 92:1302–1304. 1997.PubMed/NCBI
|
|
23
|
Udell JA, Wang CS, Tinmouth J, Fitzgerald
JM, Ayas NT, Simel DL, Schulzer M, Mak E and Yoshida EM: Does this
patient with liver disease have cirrhosis? JAMA. 307:832–842. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pang Q, Zhang JY, Xu XS, Song SD, Qu K,
Chen W, Zhou YY, Miao RC, Liu SS, Dong YF and Liu C: Significance
of platelet count and platelet-based models for hepatocellular
carcinoma recurrence. World J Gastroenterol. 21:5607–5621. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ho SY, Liu PH, Hsu CY, Chiou YY, Su CW,
Lee YH, Huang YH, Lee FY, Hou MC and Huo TI: Prognostic performance
of ten liver function models in patients with hepatocellular
carcinoma undergoing radiofrequency ablation. Sci Rep. 8:8432018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chung HA, Kim JH, Hwang Y, Hong SC, Ko SY,
Choe WH and Kwon SY: Noninvasive fibrosis marker can predict
recurrence of hepatocellular carcinoma after radiofrequency
ablation. Saudi J Gastroenterol. 22:57–63. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han S, Lee S, Yang JD, Leise MD, Ahn JH,
Kim S, Jung K, Gwak MS, Kim GS and Ko JS: Risk of posttransplant
hepatocellular carcinoma recurrence is greater in recipients with
higher platelet counts in living donor liver transplantation. Liver
Transpl. 24:44–55. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gu L, Wen W, Wu Z, Bai K, Liu W, Lai G and
Li D: Abnormal platelet count correlates with poor survival in
hepatocellular carcinoma. Infection International. 6:93–102. 2018.
View Article : Google Scholar
|
|
29
|
Metussin A, Patanwala I and Cross TJ:
Partial hepatectomy vs. transcatheter arterial chemoembolization
for resectable multiple hepatocellular carcinoma beyond Milan
Criteria: A RCT. J Hepatol. 62:747–748. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pang Q, Liu C, Zhang JY, Qu K, Song SD,
Liu SS and Xu XS: Serotonin in liver tumor: Friend or foe?
Hepatology. 62:3192015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pang Q, Liu C, Qu K, Liu S and Berasain C:
Conflicting relationship between platelets and prognosis of
hepatocellular carcinoma: Is platelet-derived serotonin involved
in? Liver Int. 35:24842015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Du QC, Hu CL, Wang YY and Zhou Y:
Comparison of the prognostic value of platelet-based prognostic
models in patients with malignant hepatic tumors after TACE
therapy. Acta Cir Bras. 34:e2019007102019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yoon JH, Park JW and Lee JM: Noninvasive
diagnosis of hepatocellular carcinoma: Elaboration on Korean liver
cancer study group-national cancer center Korea practice guidelines
compared with other guidelines and remaining issues. Korean J
Radiol. 17:7–24. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Heimbach JK, Kulik LM, Finn RS, Sirlin CB,
Abecassis MM, Roberts LR, Zhu AX, Murad MH and Marrero JA: AASLD
guidelines for the treatment of hepatocellular carcinoma.
Hepatology. 67:358–380. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Marrero JA, Ahn J and Rajender Reddy K;
Americal College of Gastroenterology, : ACG clinical guideline: The
diagnosis and management of focal liver lesions. Am J
Gastroenterol. 109:1328–1347. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Korean Society of Abdominal Radiology, .
Diagnosis of hepatocellular carcinoma with gadoxetic acid-enhanced
MRI: 2016 consensus recommendations of the Korean Society of
abdominal radiology. Korean J Radiol. 18:427–443. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Paradis V and Bedossa P: In the new area
of noninvasive markers of hepatocellular carcinoma. J Hepatol.
46:9–11. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gustafsson BI, Friman S, Mjornstedt L,
Olausson M and Backman L: Liver transplantation for polycystic
liver disease-indication and outcome. Transplant Proc. 35:813–814.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gosalia AJ, Martin P and Jones PD:
Advances and future directions in the treatment of hepatocellular
carcinoma. Gastroenterol Hepatol (NY). 13:398–410. 2017.
|
|
40
|
Bruix J, Gores GJ and Mazzaferro V:
Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut.
63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Graf D, Vallböhmer D, Knoefel WT, Kröpil
P, Antoch G, Sagir A and Häussinger D: Multimodal treatment of
hepatocellular carcinoma. Eur J Intern Med. 25:430–7. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Child CG and Turcotte JG: Surgery and
portal hypertension. Child CG: The liver and portal hypertension
Philadelphia: WB Saunders; pp. 50–72. 1964
|
|
43
|
Lee IC, Chan CC, Huang YH, Huo TI, Chu CJ,
Lai CR, Lee PC, Su CW, Hung HH, Wu JC, et al: Comparative analysis
of noninvasive models to predict early liver fibrosis in hepatitis
B e Antigen-negative Chronic Hepatitis B. J Clin Gastroenterol.
45:278–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Poynard T and Bedossa P: Age and platelet
count: A simple index for predicting the presence of histological
lesions in patients with antibodies to hepatitis C virus. METAVIR
and CLINIVIR Cooperative Study Groups. J Viral Hepat. 4:199–208.
2010. View Article : Google Scholar
|
|
45
|
Islam S, Antonsson L, Westin J and Lagging
M: Cirrhosis in hepatitis C virus- infected patients can be
excluded using an index of standard biochemical serum markers.
Scand J Gastroenterol. 40:867–872. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cross TJ, Rizzi P, Berry PA, Bruce M,
Portmann B and Harrison PM: King's Score: An accurate marker of
cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol.
21:730–738. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Park YE, Kim BK, Park JY, Kim DY, Ahn SH,
Han KH, Han S, Jeon MY, Heo JY and Song K: Gamma-glutamyl
transpeptidase-to-platelet ratio is an independent predictor of
hepatitis B virus-related liver cancer. J Gastroenterol Hepatol. 64
(Suppl):S3432016.
|
|
48
|
Zhou K, Gao CF, Zhao YP, Liu HL, Zheng RD,
Xian JC, Xu HT, Mao YM, Zeng MD and Lu LG: Simpler score of routine
laboratory tests predicts liver fibrosis in patients with chronic
hepatitis B. J Gastroenterol Hepatol. 25:1569–1577. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Güzelbulut F, Çetınkaya ZA, Sezıklı M,
Yaşar B, Ozkara S and Övünç AO: AST-platelet ratio index, Forns
index and FIB-4 in the prediction of significant fibrosis and
cirrhosis in patients with chronic hepatitis C. Turk J
Gastroenterol. 22:279–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Seto WK, Lee CF, Lai CL, Ip PP, Fong DY,
Fung J, Wong DK and Yuen MF: A new model using routinely available
clinical parameters to predict significant liver fibrosis in
chronic hepatitis B. PLoS One. 6:e230772011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fung J, Lai CL, Fong DY, Yuen JC, Wong DK
and Yuen MF: Correlation of liver biochemistry with liver stiffness
in chronic hepatitis B and development of a predictive model for
liver fibrosis. Liver Int. 28:1408–1416. 2010. View Article : Google Scholar
|
|
52
|
Lee JH, Yoon JH, Lee CH, Myung SJ, Keam B,
Kim BH, Chung GE, Kim W, Kim YJ, Jang JJ and Lee HS: Complete blood
count reflects the degree of oesophageal varices and liver fibrosis
in virus-related chronic liver disease patients. J Viral Hepat.
16:444–452. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Testa R, Testa E, Giannini E, Borro P,
Milazzo S, Isola L, Ceppa P, Lantieri PB and Risso D: Noninvasive
ratio indexes to evaluate fibrosis staging in chronic hepatitis C:
Role of platelet count/spleen diameter ratio index. J Intern Med.
260:142–150. 2010. View Article : Google Scholar
|
|
54
|
Zheng J, Cai J, Li H, Zeng K, He L, Fu H,
Zhang J, Chen L, Yao J, Zhang Y and Yang Y: Neutrophil to
lymphocyte ratio and platelet to lymphocyte ratio as prognostic
predictors for hepatocellular carcinoma patients with various
treatments: A meta-analysis and systematic review. Cell Physiol
Biochem. 44:967–981. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Labori KJ, Guren MG, Brudvik KW, Røsok BI,
Waage A, Nesbakken A, Larsen S, Dueland S, Edwin B and Bjørnbeth
BA: Resection of synchronous liver metastases between radiotherapy
and definitive surgery for locally advanced rectal cancer: Short
term surgical outcomes, overall and recurrence free survivals.
Colorectal Dis. 19:731–738. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Huang W, Skanderup AJ and Lee CG: Advances
in genomic hepatocellular carcinoma research. Gigascience.
7:gly1352018. View Article : Google Scholar
|
|
57
|
Hussain SA, Ferry DR, El-Gazzaz G, Mirza
DF, James ND, McMaster P and Kerr DJ: Hepatocellular carcinoma. Ann
Oncol. 12:161–172. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhong JH, Peng NF, You XM, Ma L, Xiang X,
Wang YY, Gong WF, Wu FX, Xiang BD and Li LQ: Tumor stage and
primary treatment of hepatocellular carcinoma at a large tertiary
hospital in China: A real-world study. Oncotarget. 8:18296–18302.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Imamura H, Tanaka E, Matsuyama Y, Miyagawa
S I, Kawasaki S, Kubota K, Takayama T and Makuuchi M: Risk factors
contributing to early and late phases of intrahepatic recurrence of
hepatocellular carcinoma (HCC) after hepatectomy. Gastroenterology.
118:A9162000. View Article : Google Scholar
|
|
60
|
Minagawa M, Makuuchi M, Takayama T and
Kokudo N: Selection criteria for repeat hepatectomy in patients
with recurrent hepatocellular carcinoma. Ann Surg. 238:703–710.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang X, Li C, Wen T, Yan L, Li B, Yang J,
Wang W, Xu M, Lu W and Jiang L: Appropriate treatment strategies
for intrahepatic recurrence after curative resection of
hepatocellular carcinoma initially within the Milan criteria:
According to the recurrence pattern. Eur J Gastroenterol Hepatol.
27:933–940. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hasegawa K, Kokudo N, Makuuchi M, Izumi N,
Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O and
Matsuyama Y: Comparison of resection and ablation for
hepatocellular carcinoma: A cohort study based on a Japanese
nationwide survey. J Hepatol. 58:724–729. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
He AD, Xie W, Song W, Ma YY, Liu G, Liang
ML, Da XW, Yao GQ, Zhang BX, Gao CJ, et al: Platelet releasates
promote the proliferation of hepatocellular carcinoma cells by
suppressing the expression of KLF6. Sci Rep. 7:39892017. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wojtukiewicz MZ, Sierko E, Hempel D,
Tucker SC and Honn KV: Platelets and cancer angiogenesis nexus.
Cancer Metastasis Rev. 36:249–262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Pang Q, Qu K, Zhang JY, Song SD, Liu SS,
Tai MH, Liu HC and Liu C: The prognostic value of platelet count in
patients with hepatocellular carcinoma. Medicine. 94. Baltimore:
pp. e14312015, View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Qin W, Wang L, Hu B, Leng S, Tian H, Luo
H, Yao J, Chen X, Wu C, Chen G and Yang Y: A novel score predicts
HBV-related hepatocellular carcinoma recurrence after hepatectomy:
A retrospective multicenter study. J Gastrointest Surg. 23:922–932.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bhatti I, Peacock O, Lloyd G, Larvin M and
Hall RI: Preoperative hematologic markers as independent predictors
of prognosis in resected pancreatic ductal adenocarcinoma:
Neutrophil-lymphocyte vs. plateletlymphocyte ratio. Am J Surg.
200:197–203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Saffroy R, Pham P, Reffas M, Takka M,
Lemoine A and Debuire B: New perspectives and strategy research
biomarkers for hepatocellular carcinoma. Clin Chem Lab Med.
45:1169–1179. 2007. View Article : Google Scholar : PubMed/NCBI
|
